A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
- Author
- BLOM, Dirk J1 ; HALA, Tomas3 ; MONSALVO, Maria Laura12 ; TSIRTSONIS, Kate13 ; KIM, Jae B12 ; SCOTT, Rob12 ; WASSERMAN, Scott M12 ; STEIN, Evan A9 ; BOLOGNESE, Michael5 ; LILLESTOL, Michael J6 ; TOTH, Phillip D7 ; BURGESS, Lesley2 ; CESKA, Richard4 ; ROTH, Eli8 ; KOREN, Michael J10 ; BALLANTYNE, Christie M11
[1] Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa
[2] TREAD Research, Cardiology Unit, Department of Internal Medicine, Tygerberg Hospital and Stellenbosch University, Parow, South Africa
[3] Center for Clinical and Basic Research, Pardubice, Czech Republic
[4] Center of Preventive Cardiology, Third Department of Internal Medicine, Charles University, Prague, Czech Republic
[5] Bethesda Health Research Center, Bethesda, MD, United States
[6] Lillestol Research, Fargo, ND, United States
[7] Midwest Institute for Clinical Research, Indianapolis, United States
[8] Sterling Research Group, Cincinnati, United States
[9] Metabolic and Atherosclerosis Research Center, Cincinnati, United States
[10] Jacksonville Center for Clinical Research, Jacksonville, FL, United States
[11] Baylor College of Medicine and the Houston Methodist DeBakey Heart and Vascular Center, Houston, United States
[12] Amgen, Thousand Oaks, CA, United States
[13] Amgen, Uxbridge, United Kingdom
DESCARTES Investigators - Source
The New England journal of medicine. 2014, Vol 370, Num 19, pp 1809-1819, 11 p ; ref : 16 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Hyperlipémie Lipide Médecine Dyslipémie Maladie métabolique
- Keyword (en)
- Hyperlipemia Lipids Medicine Dyslipemia Metabolic diseases
- Keyword (es)
- Hiperlipemia Lípido Medicina Dislipemia Metabolismo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B22 Metabolic diseases / 002B22A Disorders of blood lipids. Hyperlipoproteinemia
- Discipline
- Generalities in medical sciences Metabolic diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 28478616
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa1316222 
https://dx.doi.org/10.1056/NEJMoa1316222
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1316222\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"1809\";s:8:\"\u0000*\u0000epage\";s:4:\"1819\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BLOM\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Dirk J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"HALA, Tomas\";i:1;s:21:\"MONSALVO, Maria Laura\";i:2;s:16:\"TSIRTSONIS, Kate\";i:3;s:10:\"KIM, Jae B\";i:4;s:10:\"SCOTT, Rob\";i:5;s:18:\"WASSERMAN, Scott M\";i:6;s:13:\"STEIN, Evan A\";i:7;s:18:\"BOLOGNESE, Michael\";i:8;s:20:\"LILLESTOL, Michael J\";i:9;s:15:\"TOTH, Phillip D\";i:10;s:15:\"BURGESS, Lesley\";i:11;s:14:\"CESKA, Richard\";i:12;s:9:\"ROTH, Eli\";i:13;s:16:\"KOREN, Michael J\";i:14;s:22:\"BALLANTYNE, Christie M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1316222\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"1809\";s:8:\"\u0000*\u0000epage\";s:4:\"1819\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BLOM\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Dirk J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"HALA, Tomas\";i:1;s:21:\"MONSALVO, Maria Laura\";i:2;s:16:\"TSIRTSONIS, Kate\";i:3;s:10:\"KIM, Jae B\";i:4;s:10:\"SCOTT, Rob\";i:5;s:18:\"WASSERMAN, Scott M\";i:6;s:13:\"STEIN, Evan A\";i:7;s:18:\"BOLOGNESE, Michael\";i:8;s:20:\"LILLESTOL, Michael J\";i:9;s:15:\"TOTH, Phillip D\";i:10;s:15:\"BURGESS, Lesley\";i:11;s:14:\"CESKA, Richard\";i:12;s:9:\"ROTH, Eli\";i:13;s:16:\"KOREN, Michael J\";i:14;s:22:\"BALLANTYNE, Christie M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1316222\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1316222\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"1809\";s:8:\"\u0000*\u0000epage\";s:4:\"1819\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BLOM\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Dirk J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"HALA, Tomas\";i:1;s:21:\"MONSALVO, Maria Laura\";i:2;s:16:\"TSIRTSONIS, Kate\";i:3;s:10:\"KIM, Jae B\";i:4;s:10:\"SCOTT, Rob\";i:5;s:18:\"WASSERMAN, Scott M\";i:6;s:13:\"STEIN, Evan A\";i:7;s:18:\"BOLOGNESE, Michael\";i:8;s:20:\"LILLESTOL, Michael J\";i:9;s:15:\"TOTH, Phillip D\";i:10;s:15:\"BURGESS, Lesley\";i:11;s:14:\"CESKA, Richard\";i:12;s:9:\"ROTH, Eli\";i:13;s:16:\"KOREN, Michael J\";i:14;s:22:\"BALLANTYNE, Christie M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1316222\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"1809\";s:8:\"\u0000*\u0000epage\";s:4:\"1819\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BLOM\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Dirk J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"HALA, Tomas\";i:1;s:21:\"MONSALVO, Maria Laura\";i:2;s:16:\"TSIRTSONIS, Kate\";i:3;s:10:\"KIM, Jae B\";i:4;s:10:\"SCOTT, Rob\";i:5;s:18:\"WASSERMAN, Scott M\";i:6;s:13:\"STEIN, Evan A\";i:7;s:18:\"BOLOGNESE, Michael\";i:8;s:20:\"LILLESTOL, Michael J\";i:9;s:15:\"TOTH, Phillip D\";i:10;s:15:\"BURGESS, Lesley\";i:11;s:14:\"CESKA, Richard\";i:12;s:9:\"ROTH, Eli\";i:13;s:16:\"KOREN, Michael J\";i:14;s:22:\"BALLANTYNE, Christie M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1316222\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:66:\"A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2014\";s:9:\"\u0000*\u0000volume\";s:3:\"370\";s:8:\"\u0000*\u0000issue\";s:2:\"19\";s:8:\"\u0000*\u0000spage\";s:4:\"1809\";s:8:\"\u0000*\u0000epage\";s:4:\"1819\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BLOM\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Dirk J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:11:\"HALA, Tomas\";i:1;s:21:\"MONSALVO, Maria Laura\";i:2;s:16:\"TSIRTSONIS, Kate\";i:3;s:10:\"KIM, Jae B\";i:4;s:10:\"SCOTT, Rob\";i:5;s:18:\"WASSERMAN, Scott M\";i:6;s:13:\"STEIN, Evan A\";i:7;s:18:\"BOLOGNESE, Michael\";i:8;s:20:\"LILLESTOL, Michael J\";i:9;s:15:\"TOTH, Phillip D\";i:10;s:15:\"BURGESS, Lesley\";i:11;s:14:\"CESKA, Richard\";i:12;s:9:\"ROTH, Eli\";i:13;s:16:\"KOREN, Michael J\";i:14;s:22:\"BALLANTYNE, Christie M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:66:\"A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
